ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-47

  1. 1,416 Posts.
    lightbulb Created with Sketch. 264
    Yes a great initiative and a definitive stamp on who is helming the ship now.

    The market will need assurances and an updated on the multiplex testing timeframes to market now to keep the ship steady.

    Its all up to batteries now to avoid that cap raise and these prices. It would be a travesty for those who bought in at 26c to be raising at say 1/8 of that value.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.